Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1

Study ID Citation

Faulk KE, Kairalla JA, Hibbitts E, Long-Boyle J, Devidas M, August A, Gore L, Raetz E, Hunger SP, Loh ML, Teachey DT, Brown P, Breese EH, Kotecha RS, Guest E. Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1. Blood Adv. 2026 Jan 13;10(1):70-74. doi: 10.1182/bloodadvances.2025017013. PMID: 40991382; PMCID: PMC12804146.

Abstract

No abstract provided.

Link To Publication opens in a new tab